Related Experiment Video
Updated: Apr 14, 2026
07:35
Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
Published on: April 25, 2014
13.3K
Multidrug-Resistant Tuberculosis and Extensively Drug-Resistant Tuberculosis
Kwonjune J Seung1, Salmaan Keshavjee1, Michael L Rich1
1Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts 02115 Department of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts 02115 Partners In Health, Boston, Massachusetts 02215.
Cold Spring Harbor Perspectives in Medicine
|April 29, 2015
Summary
Drug-resistant tuberculosis (TB) is a major global health threat. Early detection and tailored treatment, including community-based care, offer hope for curing multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB.
Area of Science:
- Global Health
- Infectious Diseases
- Microbiology
Background:
- Drug-resistant tuberculosis (TB) poses a significant challenge to global health control efforts.
- Multidrug-resistant (MDR) TB, resistant to isoniazid and rifampicin, is difficult to treat with standard therapies.
- Extensively drug-resistant (XDR) TB involves resistance to fluoroquinolones and second-line injectables, further complicating treatment.
Purpose of the Study:
- To highlight the urgent global challenge of drug-resistant tuberculosis.
- To underscore the difficulties in treating MDR and XDR TB strains.
- To emphasize the potential for successful treatment with early detection and appropriate regimens.
Main Methods:
- The abstract discusses the epidemiology and causes of drug-resistant TB, including weak health systems and incorrect treatment.
- It reviews the characteristics of MDR and XDR TB strains.
- It explores treatment strategies and the role of community-based programs.
Main Results:
- In 2012, MDR-TB caused an estimated 450,000 new cases and 170,000 deaths globally.
- Cure is possible for MDR and XDR TB patients through early resistance identification and tailored treatment regimens.
- Community-based programs show promise in improving treatment adherence and outcomes.
Conclusions:
- Addressing the spread of drug-resistant TB requires strengthening medical systems and improving treatment practices.
- Early diagnosis and individualized treatment plans are crucial for managing MDR and XDR TB.
- Community-based approaches can overcome socioeconomic barriers and enhance patient outcomes for drug-resistant TB.
Related Concept Videos
01:28Pulmonary Tuberculosis V
922
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
922
01:29Pulmonary Tuberculosis I
1.5K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.5K
01:25Mechanism of Antibiotic Resistance in MRSA
135
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
135
01:26Pulmonary Tuberculosis IV
746
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
746
01:30Development of Antibiotic Resistance
2.0K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
01:31Pulmonary Tuberculosis III
1.6K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.6K